Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Postprandial Response of Fresh-squeezed and Processed Orange Juice of Lean and Obese Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03032120
Recruitment Status : Completed
First Posted : January 26, 2017
Last Update Posted : February 2, 2017
Sponsor:
Information provided by (Responsible Party):
Thais Cesar, São Paulo State University

Tracking Information
First Submitted Date  ICMJE January 16, 2017
First Posted Date  ICMJE January 26, 2017
Last Update Posted Date February 2, 2017
Study Start Date  ICMJE July 2012
Actual Primary Completion Date November 2012   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: January 23, 2017)
Assessment of the changes on glucose, insulin, leptin, and adiponectin levels over the time times 0, 30, 60, 120, and 300 min [ Time Frame: Up to 6 month after blood collection of glucose, insulin, leptin, and adiponectin. ]
Determination of glucose, insulin, leptin, adiponectin in the blood serum.
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: January 23, 2017)
  • Assessment of the changes on blood serum antioxidant biomarkers before and after each beverage intervention [ Time Frame: Up to 6 month after blood collection of antioxidant biomarkers (TBARS and ABTS). ]
    Determination of TBARS and ABTS in the blood serum.
  • Assessing of change on prospective food intake after each beverage intervention [ Time Frame: Up to 3 weeks after the application of each 24-h food recall. ]
    Evaluation of prospective food intake by 24-h food recall.
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Postprandial Response of Fresh-squeezed and Processed Orange Juice of Lean and Obese Subjects
Official Title  ICMJE Postprandial Response of Fresh-squeezed and Processed Orange Juice on Appetite-related Biomarkers and Antioxidant-status in Lean and Obese Subjects
Brief Summary This study aimed investigated the acute intake effect of fresh-squeezed orange juice (FOJ), processed orange juice (POJ), and an isoenergetic orange-flavored drink (control) on postprandial response of blood serum biomarkers (glucose, insulin, leptin and adiponectin), anti-oxidatant status, and prospective food intake in lean and obese subjects.
Detailed Description Non-randomized crossover clinical trial, in which eligible participants (n= 36) were allocated in accordance with their body mass index in two groups, lean (n = 18, 9 women/9 men) and obese (n = 18, 9 women/9 men). Subjects of both groups intake of one single dose (5 mL/kg body weight) of isoenergetic beverages in three different phases: (1) fresh-squeezed orange juice (FOJ), (2) commercial processed orange juice (POJ) and (3) an energy and sugars-matched orange-flavored drink (control), with a washout period of seven days among each beverage. Thirty minutes after the intake of each beverage, the participants had a flavonoid-free standard breakfast, which contained coffee (infusion), milk, sugar or sweetener, white bread sandwich with lean ham and light cream cheese, salted and sweet biscuits. Posteriorly, blood samples (10 mL) were collected at 30, 60, 120 and 300 min after each intervention with a catheter installed in a vein of the arm. After blood collection, the volunteers were instructed to record all meals throughout the day, noting the amount eaten of each food. The sample number took into account variations in blood serum glucose with a type I error α = 0.05 and a type II error β = 0.2 (80% power). Primary output were the modification on glucose or insulin concentration induced by different beverages in some point of the curves. The secondary output was the antioxidant activity induced by FOJ and/or POJ. Kolmogorov Smirnov and Levene test, respectively assessed normality and homogeneity of the data. Area under the curve (AUC0-300 min) was calculated by the clearance of the appetite related-biomarkers (glucose, insulin, leptin and adiponectin) during 300 min for each trial phase Other parameters, as maximum concentration (Cmax), and time to reach maximum blood concentration (Tmax) were also estimated. AUC was determined with the trapezoidal method by Microcal Software Inc., Origin® 6.0. One-way analysis of variance (ANOVA) followed by Sidak post hoc was applied to compared the effect of interventions on appetite related-biomarkers, anti-oxidant status and beverage composition. P significance was set up ≤ 0.05.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Condition  ICMJE Obesity
Intervention  ICMJE
  • Dietary Supplement: Orange juice
    Lean and obese subjects drank one single dose (5 mL/kg body weight) of fresh-squeezed orange juice (FOJ) and processed orange juice (POJ) followed by an ad libitum breakfast. A washout period of seven days among each beverage (FOJ, POJ and control) was applied.
  • Dietary Supplement: Control
    Lean and obese subjects drank one single dose (5 mL/kg body weight) of an energy and sugars-matched orange-flavored drink (control), followed by an ad libitum breakfast. A washout period of seven days among each beverage (FOJ, POJ and control) was applied.
Study Arms  ICMJE
  • Experimental: Fresh orange juice
    Intervention: The subjects drank 5 mL/kg body weight of fresh-squeezed orange juice (FOJ).
    Intervention: Dietary Supplement: Orange juice
  • Experimental: Processed orange juice
    Intervention: The subjects drank 5 mL/kg body weight of processed orange juice (POJ).
    Intervention: Dietary Supplement: Orange juice
  • Experimental: Control
    The subjects drank 5 mL/kg body weight of control drink compounded by water mixed with sugars in a similar concentration of orange juices (5.2% of sucrose, 2.5% of fructose, 2.1% of glucose, 0.75% of citric acid, and malic acid 0.25%, flavored and colored with some drops of orange essence).
    Intervention: Dietary Supplement: Control
Publications * Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: January 23, 2017)
36
Original Actual Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE November 2012
Actual Primary Completion Date November 2012   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  1. Healthy men and women volunteers;
  2. Volunteers with BMI between 18.5 to 39.9 kg/m2.

Exclusion criteria:

  1. Volunteers with BMI between more than 40 kg/m2;
  2. Smokers volunteers;
  3. Volunteers who are in treatment with drugs (except contraceptives), vitamins and nutritional supplements;
  4. Volunteers who are dieting for weight loss;
  5. Volunteers who gained or lost more than 3 kg of weight in the last 3 months;
  6. Volunteers who consume more than 20 g of alcohol per day
  7. Volunteers who practicing intense physical activity (more than 5 hours per week).
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 59 Years   (Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03032120
Other Study ID Numbers  ICMJE SaoPSU17
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Plan Description: There was no plan to share individual participant data (IPD) to other researchers.
Responsible Party Thais Cesar, São Paulo State University
Study Sponsor  ICMJE São Paulo State University
Collaborators  ICMJE Not Provided
Investigators  ICMJE Not Provided
PRS Account São Paulo State University
Verification Date February 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP